BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32409602)

  • 1. Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.
    Morianos I; Trochoutsou AI; Papadopoulou G; Semitekolou M; Banos A; Konstantopoulos D; Manousopoulou A; Kapasa M; Wei P; Lomenick B; Belaidi E; Kalamatas T; Karageorgiou K; Doskas T; Sallusto F; Pan F; Garbis SD; Quintana FJ; Xanthou G
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12269-12280. PubMed ID: 32409602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.
    Hernandez-Mir G; McGeachy MJ
    PLoS One; 2017; 12(3):e0173655. PubMed ID: 28288184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
    Wu B; Zhang S; Guo Z; Bi Y; Zhou M; Li P; Seyedsadr M; Xu X; Li JL; Markovic-Plese S; Wan YY
    Immunity; 2021 Feb; 54(2):308-323.e6. PubMed ID: 33421362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
    Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
    Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
    Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic Signaling as a Regulator of Th17 Cell Plasticity.
    Fernández D; Flores-Santibáñez F; Neira J; Osorio-Barrios F; Tejón G; Nuñez S; Hidalgo Y; Fuenzalida MJ; Meza D; Ureta G; Lladser A; Pacheco R; Acuña-Castillo C; Guixé V; Quintana FJ; Bono MR; Rosemblatt M; Sauma D
    PLoS One; 2016; 11(6):e0157889. PubMed ID: 27322617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function.
    Lee JJ; Jeong HJ; Kim MK; Wee WR; Lee WW; Kim SU; Sung C; Yang YH
    Purinergic Signal; 2014; 10(2):357-65. PubMed ID: 24043462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.
    Chalmin F; Mignot G; Bruchard M; Chevriaux A; Végran F; Hichami A; Ladoire S; Derangère V; Vincent J; Masson D; Robson SC; Eberl G; Pallandre JR; Borg C; Ryffel B; Apetoh L; Rébé C; Ghiringhelli F
    Immunity; 2012 Mar; 36(3):362-73. PubMed ID: 22406269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD73
    Ko MK; Shao H; Kaplan HJ; Sun D
    Front Immunol; 2020; 11():601272. PubMed ID: 33343573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
    Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
    J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
    Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
    Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
    Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
    Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
    PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
    Martin F; Apetoh L; Ghiringhelli F
    Trends Mol Med; 2012 Dec; 18(12):742-9. PubMed ID: 23083809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
    Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
    Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectonucleotidases in Intestinal and Hepatic Inflammation.
    Vuerich M; Robson SC; Longhi MS
    Front Immunol; 2019; 10():507. PubMed ID: 30941139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.